In db/db mice with type 2 diabetes, Cat-S inhibitors or PAR2 inhibitors have been reported to reduce albuminuria and glomerulosclerosis, as well as other organ complications such as diabetic retinopathy (11). Here, PIMREG is linked to glomerulosclerosis.